Fimbrial profiles predict virulence of uropathogenic Escherichia coli Strains: Contribution of Ygi and Yad fimbriae

Infection and Immunity

Volumn 79, Issue 12, 2011, Pages 4753-4763

  Spurbeck, Rachel R ^a   Stapleton, Ann E ^b   Johnson, James R ^c   Walk, Seth T ^a   Hooton, Thomas M ^d   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIMBRIA PROTEIN; PROTEIN YADN; PROTEIN YFCV; PROTEIN YGIL; UNCLASSIFIED DRUG; ESCHERICHIA COLI PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BACTERIURIA; BIOFILM; CELL MOTILITY; COMMENSAL ESCHERICHIA COLI; CYSTITIS; EPITHELIUM CELL; FIMBRIA; GENE DELETION; HUMAN; HUMAN CELL; MOLECULAR PHYLOGENY; MOUSE; NONHUMAN; OPERON; PRIORITY JOURNAL; PYELONEPHRITIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; BLADDER; CBA MOUSE; CELL LINE; CLASSIFICATION; CYTOLOGY; DISEASE MODEL; ESCHERICHIA COLI INFECTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYLOGENY; PHYSIOLOGY; VIRULENCE;

ANIMALS; BACTERIAL ADHESION; BIOFILMS; CELL LINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; FIMBRIAE, BACTERIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICE; MICE, INBRED CBA; OPERON; PHYLOGENY; URINARY BLADDER; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84862909093     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05621-11     Document Type: Article

References (54)

1. Antao, E. M., L. H. Wieler, and C. Ewers. 2009. Adhesive threads of extraintestinal pathogenic Escherichia coli. Gut Pathog. 1:22.
2. Bikandi, J., R. San Millan, A. Rementeria, and J. Garaizar. 2004. In silico analysis of complete bacterial genomes: PCR, AFLP-PCR and endonuclease restriction. Bioinformatics 20:798-799.
3. Bryan, A., et al. 2006. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Infect. Immun. 74:1072-1083.
4. Clermont, O., et al. 2011. Animal and human pathogenic Escherichia coli strains share common genetic backgrounds. Infect. Genet. Evol. 11:654-662.
5. Connell, I., et al. 1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl. Acad. Sci. U. S. A. 93:9827-9832.
6. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
7. Foxman, B. 2003. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49:53-70.
8. Fronzes, R., H. Remaut, and G. Waksman. 2008. Architectures and biogenesis of non-flagellar protein appendages in Gram-negative bacteria. EMBO J. 27:2271-2280.
9. Goluszko, P., et al. 1997. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J. Clin. Invest. 99:1662-1672.
10. Goluszko, P., et al. 1997. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J. Infect. Dis. 176:158-167.
11. Goslee, S. C., and D. L. Urban. 2007. The ecodist package for dissimilaritybased analysis of ecological data. J. Stat. Softw. 22:1-19.
12. Hagan, E. C., A. L. Lloyd, D. A. Rasko, G. J. Faerber, and H. L. Mobley. 2010. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog. 6:e1001187.
13. Hancock, V., R. M. Vejborg, and P. Klemm. 2010. Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation. Mol. Genet. Genomics 284:437-454.
14. Hooton, T. M., et al. 2000. A prospective study of asymptomatic bacteriuria in sexually active young women. N. Engl. J. Med. 343:992-997.
15. Hopkins, W. J., J. L. Jensen, D. T. Uehling, and E. Balish. 1986. In vitro and in vivo adherence of uropathogenic Escherichia coli strains. J. Urol. 135: 1319-1321.
16. Hull, R. A., et al. 2002. Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect. Immun. 70:6481-6484.
17. Jarrell, K. F. 2009. Pili and flagella: current research and future trends. Caister Academic Press, Norfolk, United Kingdom.
18. Johnson, D. E., C. V. Lockatell, M. Hall-Craigs, H. L. Mobley, and J. W. Warren. 1987. Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J. Urol. 138:632-635.
19. Johnson, J. R. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:80-128.
20. Johnson, J. R., and J. J. Brown. 1996. A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(α1-4)Gal-binding PapG adhesins of Escherichia coli. J. Infect. Dis. 173: 920-926.
21. Johnson, J. R., et al. 2006. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J. Infect. Dis. 194:1141-1150.
22. Johnson, J. R., et al. 2005. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J. Infect. Dis. 191:46-50.
23. Johnson, J. R., K. Owens, A. Gajewski, and M. A. Kuskowski. 2005. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J. Clin. Microbiol. 43:6064-6072.
24. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.
25. Kreft, B., et al. 1995. S fimbriae of uropathogenic Escherichia coli bind to primary human renal proximal tubular epithelial cells but do not induce expression of intercellular adhesion molecule 1. Infect. Immun. 63:3235-3238.
26. Lane, M. C., C. J. Alteri, S. N. Smith, and H. L. Mobley. 2007. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc. Natl. Acad. Sci. U. S. A. 104:16669-16674.
27. Lane, M. C., et al. 2005. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect. Immun. 73:7644-7656.
28. Lane, M. C., and H. L. Mobley. 2007. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int. 72:19-25.
29. Lane, M. C., A. N. Simms, and H. L. Mobley. 2007. complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J. Bacteriol. 189:5523-5533.
30. Lim, J. K., et al. 1998. In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. Infect. Immun. 66: 3303-3310.
31. Lomberg, H., M. Hellstrom, U. Jodal, and C. Svanborg Eden. 1989. Secretor state and renal scarring in girls with recurrent pyelonephritis. FEMS Microbiol. Immunol. 1:371-375.
32. Lugering, A., I. Benz, S. Knochenhauer, M. Ruffing, and M. A. Schmidt. 2003. The Pix pilus adhesin of the uropathogenic Escherichia coli strain X2194 (O2:K:H6) is related to Pap pili but exhibits a truncated regulatory region. Microbiology 149:1387-1397.
33. Melican, K., et al. 2011. Uropathogenic Escherichia coli P and type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog. 7:e1001298.
34. Miyazaki, J., et al. 2002. Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. FEMS Immunol. Med. Microbiol. 33:23-26.
35. Mobley, H. L., et al. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
36. Nielubowicz, G. R., and H. L. Mobley. 2010. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7:430-441.
37. Ochman, H., and R. K. Selander. 1984. Standard reference strains of Escherichia coli from natural populations. J. Bacteriol. 157:690-693.
38. Pratt, L. A., and R. Kolter. 1998. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30:285-293.
39. R Development Core Team. 2010. R: a language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria.
40. Schembri, M. A., and P. Klemm. 2001. Biofilm formation in a hydrodynamic environment by novel fimh variants and ramifications for virulence. Infect. Immun. 69:1322-1328.
41. Simms, A. N., and H. L. Mobley. 2008. Multiple genes repress motility in uropathogenic Escherichia coli constitutively expressing type 1 fimbriae. J. Bacteriol. 190:3747-3756.
42. Simms, A. N., and H. L. Mobley. 2008. PapX, a P fimbrial operon-encoded inhibitor of motility in uropathogenic Escherichia coli. Infect. Immun. 76: 4833-4841.
43. Sjostrom, A. E., et al. 2009. The SfaXII protein from newborn meningitis E. coli is involved in regulation of motility and type 1 fimbriae expression. Microb. Pathog. 46:243-252.
44. Snyder, J. A., et al. 2005. Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect. Immun. 73:7588-7596.
45. Stapleton, A., S. Moseley, and W. E. Stamm. 1991. Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. J. Infect. Dis. 163:773-779.
46. Tamura, K., et al. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
47. Tenaillon, O., D. Skurnik, B. Picard, and E. Denamur. 2010. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 8:207-217.
48. Thanassi, D. G., and S. J. Hultgren. 2000. Assembly of complex organelles: pilus biogenesis in gram-negative bacteria as a model system. Methods 20: 111-126.
49. Ulett, G. C., A. N. Mabbett, K. C. Fung, R. I. Webb, and M. A. Schembri. 2007. The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation. Microbiology 153:2321-2331.
50. Vigil, P. D., et al. 2011. Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. mBio 2:e00066-11.
51. Warren, J. W., et al. 1983. A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. Rev. Infect. Dis. 5(Suppl. 1):S173-S180.
52. Warren, J. W., J. H. Tenney, J. M. Hoopes, H. L. Muncie, and W. C. Anthony. 1982. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J. Infect. Dis. 146:719-723.
53. Welch, R. A., et al. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99:17020-17024.
54. Xie, J., B. Foxman, L. Zhang, and C. F. Marrs. 2006. Molecular epidemiologic identification of Escherichia coli genes that are potentially involved in movement of the organism from the intestinal tract to the vagina and bladder. J. Clin. Microbiol. 44:2434-2441.